Trajan announces new CEO appointment – organizing for the future

Trajan announces new CEO appointment – organizing for the future

November 10, 2017

Melbourne, Victoria, Australia – 10 November 2017

Trajan Scientific and Medical (Trajan), is pleased to announce the appointment of Mr. John O’Connor as CEO of the organization from Monday 13 November 2017. Founder and current CEO Mr. Stephen Tomisich will transition to the role of Executive Chair, and says, “Having John step into the role of CEO prepares us for the next stage of Trajan’s growth.”

John has been an advisor to the Trajan Board over the past year, and has gained an intimate working knowledge of the company and its potential. Bringing over 25 years of global business experience as a Director and CEO in organizations ranging in size and scope from $10M to $1B in annual revenues, and has demonstrated an impressive track record of overseeing enterprises to realize their potential.

Photo (L-R): John O'Connor and Stephen Tomisich
Photo (L-R): John O'Connor and Stephen Tomisich.

John says, “It is a privilege to be joining Trajan as the CEO and being able to contribute to the company’s impressive and ongoing growth path. I look forward to working with the entire Trajan team around the world, in continuing to deliver outstanding value to all of our stakeholders.”

Over its first six years Trajan has built a global organization of nearly 400 staff, refreshed and renewed the infrastructure of the operations acquired, and developed through collaboration a deep technology pipeline ready for commercial translation in the coming years.

Stephen is enthusiastic about the future, “This is an exciting time for Trajan as we continue our drive to impact the world through science that benefits people.”

John O'Connor and Stephen Tomisich at Trajan Global Corporate Headquarters, Melbourne, Australia.
Photo (L-R):John O'Connor and Stephen Tomisich at Trajan Global Corporate Headquarters, Melbourne, Australia.

Download
Press release [PDF]

Media contact information
Trajan Scientific and Medical
Tel: +44 (0) 1244 403 100
media@trajanscimed.com




Also in News

Congratulations to Trajan CSO on University of Tasmania award
Congratulations to Trajan CSO on University of Tasmania award

November 14, 2017

Dr Andrew Gooley, Chief Scientific Officer of Trajan Scientific and Medical, proudly accepted the University of Tasmania Vice-Chancellor's award for outstanding contributions by adjunct and clinical title holders.

Read More

Minimizing trauma of skin biopsies - Trajan and UniQuest to form partnership for the commercialization and continued development of devices for microsampling human tissue
Minimizing trauma of skin biopsies - Trajan and UniQuest to form partnership for the commercialization and continued development of devices for microsampling human tissue

October 23, 2017

Trajan Scientific and Medical, together with UniQuest today announced their intention to form a partnership to develop and commercialize devices for microsampling human tissue using a technique discovered at The University of Queensland.

Read More

Congratulations to two ASTech leaders in The Analytical Scientist's
Congratulations to two ASTech leaders in The Analytical Scientist's "magnificent tens"

October 18, 2017

Trajan would like to congratulate Professor Emily Hilder and Professor Michael Breadmore for being recognized by the Analytical Scientist in their "10 Top 10s of analytical science" where scientists were nominated across ten categories for 2017.

Read More